Your shopping cart is currently empty

IX-207-887 is an innovative anti-arthritis compound that effectively inhibits the release of interleukin-1 (IL-1) from human monocytes and murine peritoneal macrophages in vitro. Its active concentration can reach therapeutic levels in both human rheumatoid arthritis and animal arthritis models. Furthermore, IX-207-887 exhibits a novel ability to suppress IL-1 release.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | IX-207-887 is an innovative anti-arthritis compound that effectively inhibits the release of interleukin-1 (IL-1) from human monocytes and murine peritoneal macrophages in vitro. Its active concentration can reach therapeutic levels in both human rheumatoid arthritis and animal arthritis models. Furthermore, IX-207-887 exhibits a novel ability to suppress IL-1 release. |
| Synonyms | IX 207-887 |
| Molecular Weight | 284.33 |
| Formula | C16H12O3S |
| Cas No. | 128439-98-5 |
| Smiles | COC1=CC2=CC=CC=C2\C(=C/C(O)=O)C3=C1SC=C3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.